SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-030535
Filing Date
2023-06-29
Accepted
2023-06-29 07:30:12
Documents
14
Period of Report
2023-06-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlyb-20230628.htm   iXBRL 8-K 81031
2 EX-99.1 rlyb-ex99_1.htm EX-99.1 26272
3 GRAPHIC img96626370_0.jpg GRAPHIC 21731
  Complete submission text file 0000950170-23-030535.txt   268364

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20230628_lab.xml EX-101.LAB 13904
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20230628.xsd EX-101.SCH 2452
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20230628_pre.xml EX-101.PRE 11417
8 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20230628_htm.xml XML 4884
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40693 | Film No.: 231054312
SIC: 2834 Pharmaceutical Preparations